CARDIO DIAGNOSTICS HOLDINGS INC(CDIO),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

CDIO CARDIO DIAGNOSTICS HOLDINGS INC

Market Closed 11-22 16:00:00 EST

0.2654

+0.0180

+7.28%

盘后0.2659

+0.0005+0.19%

19:58 EST

High0.2695	Low0.2400	Vol543.99K
Open0.2400	D1 Closing0.2474	Amplitude11.92%
Mkt Cap10.73M	Tradable Cap5.29M	Total Shares40.44M
T/O140.64K	T/O Rate2.73%	Tradable Shares19.92M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"CDIO","market":"US","secType":"STK","nameCN":"CARDIO DIAGNOSTICS HOLDINGS INC","latestPrice":0.2654,"timestamp":1732309200000,"preClose":0.2474,"halted":0,"volume":543994,"hourTrading":{"tag":"盘后","latestPrice":0.2659,"preClose":0.2654,"latestTime":"19:58 EST","volume":43081,"amount":11367.2276,"timestamp":1732323526956},"delay":0,"floatShares":19920600,"shares":40439810,"eps":-0.37872,"marketStatus":"Market Closed","change":0.018,"latestTime":"11-22 16:00:00 EST","open":0.24,"high":0.2695,"low":0.24,"amount":140642.9575738,"amplitude":0.11924,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.37872,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Market Trading","tradingStatus":1,"beginTime":1732525200000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":0.2474,"preHourTrading":{"tag":"盘前","latestPrice":0.2431,"preClose":0.2474,"latestTime":"09:16 EST","volume":23484,"amount":5804.335264679999,"timestamp":1732285012808},"postHourTrading":{"tag":"盘后","latestPrice":0.2659,"preClose":0.2654,"latestTime":"19:58 EST","volume":43081,"amount":11367.2276,"timestamp":1732323526956},"volumeRatio":0.31348012600170355},"requestUrl":"/m/hq/s/CDIO/wiki","defaultTab":"wiki","newsList":[{"id":"2483519085","title":"Cardio Diagnostics Holdings Third Quarter 2024 Earnings: Misses Expectations","url":"https://stock-news.laohu8.com/highlight/detail?id=2483519085","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483519085?lang=en_us&edition=fundamental","pubTime":"2024-11-16 21:59","pubTimestamp":1731765581,"startTime":"0","endTime":"0","summary":"NasdaqCM:CDIO Earnings and Revenue History November 16th 2024. All figures shown in the chart above are for the trailing 12 month  period. Revenue missed analyst estimates by 34%. Earnings per share  also missed analyst estimates by 20%.Looking ahead, revenue is forecast to grow 200% p.a. on average during the next 2 years, compared to a 22% growth forecast for the Biotechs industry in the US.The company's shares are down 35% from a week ago.It is worth noting though that we have found 6 warning signs for Cardio Diagnostics Holdings (4 make us uncomfortable!) that you need to take into consideration.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/5Vpve0Pc2F3m_L3fs2p_dQ--~B/aD02MzY7dz05NDU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/78a8c60a6283aea0450523395306d38c","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/5Vpve0Pc2F3m_L3fs2p_dQ--~B/aD02MzY7dz05NDU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/78a8c60a6283aea0450523395306d38c"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cardio-diagnostics-holdings-third-quarter-135941176.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CDIOW","CDIO"],"gpt_icon":0},{"id":"2482088086","title":"Cardio Diagnostics Holdings, Inc. to Sponsor and Showcase AI-Powered Solutions at the FLAACOs Annual Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2482088086","media":"Business Wire","labels":["Company Corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482088086?lang=en_us&edition=fundamental","pubTime":"2024-11-12 21:31","pubTimestamp":1731418260,"startTime":"0","endTime":"0","summary":"CHICAGO, November 12, 2024----Cardio Diagnostics Holdings, Inc. , an AI-powered precision cardiovascular medicine company, today announced it will sponsor and exhibit at the Florida Association of ACOs  2024 Annual Fall Conference, taking place in Orlando, FL, from November 20-22, 2024. The conference, hosted at the JW Marriott Orlando Bonnet Creek, brings together healthcare leaders and organizations focused on advancing value-based care models nationwide.The Company's CEO and Co-Founder, Meesha Dogan, Ph.D., will be speaking on a Strategic Innovation panel, exploring how AI and digital innovation are driving transformative change in value-based care, enhancing patient outcomes and managing costs effectively. The Cardio Diagnostics team will be available throughout the conference to discuss integration strategies and demonstrate how our solutions can support ACOs in their value-based care initiatives. Healthcare leaders interested in learning more about Cardio Diagnostics' precision c","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/RjAc8nb9H5h1p1YQzZ418g--~B/aD0yNzI7dz0xMDg2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/064a06532a1b078e5b5bee7dfe3e7f92","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/RjAc8nb9H5h1p1YQzZ418g--~B/aD0yNzI7dz0xMDg2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/064a06532a1b078e5b5bee7dfe3e7f92"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cardio-diagnostics-holdings-inc-sponsor-133100519.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Company Corporation","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","CDIOW","CDIO"],"gpt_icon":1},{"id":"2472111327","title":"Cardio Diagnostics Holdings Inc: CMS Issued Preliminarily Determination to Price Both Precisionchd and EPI+Gen Chd on a ‘Gapfill’ Basis","url":"https://stock-news.laohu8.com/highlight/detail?id=2472111327","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2472111327?lang=en_us&edition=fundamental","pubTime":"2024-10-01 20:42","pubTimestamp":1727786544,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241001:nFWN3LD10D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","CDIO"],"gpt_icon":0},{"id":"2472327874","title":"Cardio Diagnostics Holdings, Inc. Receives Preliminary Medicare Pricing from Centers for Medicare and Medicaid Services (CMS) for AI-Powered Cardiovascular Tests","url":"https://stock-news.laohu8.com/highlight/detail?id=2472327874","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2472327874?lang=en_us&edition=fundamental","pubTime":"2024-10-01 20:31","pubTimestamp":1727785860,"startTime":"0","endTime":"0","summary":"Preliminary CMS pricing determination marks a key milestone in gaining broad access to Medicare reimbursement.CMS recently issued a preliminarily determination to price both PrecisionCHD and Epi+Gen CHD on a ‘gapfill’ basis. This decision, following the Clinical Laboratory Fee Schedule  Annual Public Meeting held on June 25, 2024, recognizes the unique value of these tests. If finalized, this decision will be effective for claims with dates of service on or after January 1, 2025, and will allow Medicare contractors to determine pricing for PrecisionCHD and Epi+Gen CHD based on actual cost data from Cardio Diagnostics. The Medicare contractors will report to CMS preliminary gapfill pricing for calendar year 2025 by April 1, 2025.Cardio Diagnostics is an artificial intelligence-powered precision cardiovascular medicine company that makes cardiovascular disease prevention, detection, and management more accessible, personalized, and precise. The Company was formed to further develop and c","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/1kcmt2LBZWNwPuJUpp8i5g--~B/aD0yNzI7dz0xMDg2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/585507300db2208f9f3402b0f0fe979a","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/1kcmt2LBZWNwPuJUpp8i5g--~B/aD0yNzI7dz0xMDg2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/585507300db2208f9f3402b0f0fe979a"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cardio-diagnostics-holdings-inc-receives-123100224.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4504","CDIO","CHD","LU2637428348.USD","CDIOW","BK4139","BK4585","BK4082","BK4208","BK4588","CMS","CSII","BK4018","LU2346227817.USD"],"gpt_icon":1},{"id":"2468393307","title":"Potential Catalyst Right Around The Corner? CMS To Announce Preliminary Medicare Payment For Cardio Diagnostics' Heart Disease Tests","url":"https://stock-news.laohu8.com/highlight/detail?id=2468393307","media":"ACCESSWIRE","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2468393307?lang=en_us&edition=fundamental","pubTime":"2024-09-18 02:15","pubTimestamp":1726596900,"startTime":"0","endTime":"0","summary":"CHICAGO, IL / ACCESSWIRE / September 17, 2024 / By James Blacker, Benzinga. Cardio Diagnostics , the company leveraging AI to revolutionize cardiovascular disease prevention with precision epigenetics, is awaiting a crucial decision that could be a major factor in the commercial success of its flagship heart disease tests.In June of this year, the company attended an annual meeting hosted by the Centers for Medicare and Medicaid Services , where healthcare companies presented the prices they think Medicare should pay for their products and the rationale for their recommendation. At this meeting, Cardio Diagnostics submitted information and pricing recommendations for its two cutting-edge tests: Epi+Gen CHD and PrecisionCHD.Now, the company is awaiting the next important step - the CMS is expected to release its proposed payment determinations in September, based on the timeline posted by the CMS on its website. These preliminary determinations are based on the information from said ann","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/Fd1E9FrLoCWcKT6HhhuaFg--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/cf93472afa1c66c1243dda2a0581a331","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/Fd1E9FrLoCWcKT6HhhuaFg--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/cf93472afa1c66c1243dda2a0581a331"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/potential-catalyst-around-corner-cms-181500704.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4504","BK4588","LU2346227817.USD","CDIOW","CDIO","LU2637428348.USD","ACI","BK4585","CMS","BK4018","BK4113","CHD","BK4208","BK4139"],"gpt_icon":0},{"id":"2462160856","title":"Cardio Diagnostics Price Target Maintained With a $2.00/Share by Benchmark","url":"https://stock-news.laohu8.com/highlight/detail?id=2462160856","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2462160856?lang=en_us&edition=fundamental","pubTime":"2024-08-27 21:03","pubTimestamp":1724763780,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CDIO/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  August 27, 2024 09:03 ET (13:03 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CDIO"],"gpt_icon":0},{"id":"2458528370","title":"Cardio Diagnostics Holdings Inc    expected to post a loss of 11 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2458528370","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2458528370?lang=en_us&edition=fundamental","pubTime":"2024-08-10 06:35","pubTimestamp":1723242919,"startTime":"0","endTime":"0","summary":"* Cardio Diagnostics Holdings Inc     is expected to show a rise in quarterly revenue when it reports  results on August 12 (estimated) for the period ending June 30 2024   * The Chicago Illinois-base","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Cardio Diagnostics Holdings Inc    expected to post a loss of 11 cents a share - Earnings Preview","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CDIO"],"gpt_icon":1},{"id":"2455579136","title":"Cardio Diagnostics Holdings Inc. Launches CDIO.AI, A Redesigned Website Enhancing User Experience and Highlighting Our AI-Driven Cardiovascular Solutions","url":"https://stock-news.laohu8.com/highlight/detail?id=2455579136","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2455579136?lang=en_us&edition=fundamental","pubTime":"2024-07-29 20:45","pubTimestamp":1722257100,"startTime":"0","endTime":"0","summary":"CHICAGO, July 29, 2024----Cardio Diagnostics Holdings, Inc. , a leader in AI-powered precision cardiovascular medicine, today announced the launch of its redesigned website at CDIO.AI. This new site emphasizes the Company's AI-first approach and innovative scalable solutions for the prevention, detection and management of cardiovascular disease, which is the leading cause of death globally. This site also streamlines access to critical information and resources for investors, partners, patients, providers, and other key stakeholders.The redesigned website provides a significantly enhanced user experience, ensuring that each stakeholder group can easily navigate and find relevant information. Investors will find streamlined access to financial reports, stock information, and corporate governance details. Patients can access clear, concise information about Cardio Diagnostics' tests and how to obtain them, while healthcare providers benefit from simplified resources for ordering tests an","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/M3Q9HLgJPQhMbNeIfq1zrA--~B/aD0yNzI7dz0xMDg2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/389a2aab5cfcfd89d7ad0532b98866dc","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/M3Q9HLgJPQhMbNeIfq1zrA--~B/aD0yNzI7dz0xMDg2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/389a2aab5cfcfd89d7ad0532b98866dc"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cardio-diagnostics-holdings-inc-launches-124500843.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CDIOW","CDIO","BK4082","ACI","BK4139","CSII","BK4113"],"gpt_icon":0},{"id":"2446557984","title":"Cardio Diagnostics' Heart Attack Risk Assessment Test Available at Meijer Supercenter in Illinois; Shares Rise","url":"https://stock-news.laohu8.com/highlight/detail?id=2446557984","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2446557984?lang=en_us&edition=fundamental","pubTime":"2024-06-27 23:56","pubTimestamp":1719503764,"startTime":"0","endTime":"0","summary":"Cardio Diagnostics  said Thursday its Epi+Gen CHD clinical blood test is now available at Family Medicine Specialists' retail clinical location at the Meijer Supercenter in McHenry, Illinois.The test predicts the odds that an individual will have a heart attack or experience sudden death related to coronary heart disease in the next three years, the company said.Cardio Diagnostics shares were up 4.4% in recent trading.Price: 0.55, Change: +0.02, Percent Change: +4.42","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CDIO","BK4139"],"gpt_icon":0},{"id":"2446557933","title":"Cardio Diagnostics' Heart Attack Risk Assessment Test Available at Meijer Supercenter in Illinois; Shares Rise","url":"https://stock-news.laohu8.com/highlight/detail?id=2446557933","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2446557933?lang=en_us&edition=fundamental","pubTime":"2024-06-27 23:56","pubTimestamp":1719503764,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_live","symbols":["BK4139","CHD","BK4504","LU2286300806.USD","BK4585","BK4097","BK4018","CDIO","GEN","BK4588"],"gpt_icon":0},{"id":"2446534059","title":"Cardio Diagnostics Announces Its Epi+Gen CHD Heart Attack Risk Assessment Test is Now Available at Meijer Supercenter in McHenry, Illinois","url":"https://stock-news.laohu8.com/highlight/detail?id=2446534059","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2446534059?lang=en_us&edition=fundamental","pubTime":"2024-06-27 20:31","pubTimestamp":1719491460,"startTime":"0","endTime":"0","summary":"CHICAGO, June 27, 2024----Cardio Diagnostics Holdings, Inc. , an AI-driven precision cardiovascular medicine company, announced today that the Company’s clinical blood test, Epi+Gen CHD is now available at Family Medicine Specialists’  retail clinical location at the Meijer Supercenter in McHenry, Illinois.Meijer, a privately owned and family-operated retailer based in Michigan, has more than 500 locations in the heartland of America. The company’s consumers are predominately middle-aged and older adults in suburban and rural areas of the Midwest. Given that 73% of Meijer shoppers are within the Gen X and Boomers age groups of 45-years old and older, it is crucial to address the health needs of this demographic, particularly concerning heart disease.These services are particularly vital in the rural and suburban regions where most Meijer locations are situated, as these areas often have limited access to healthcare facilities. Meijer’s onsite clinic partners like FMS make precision car","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/oSggiPuAItNxnau.XMmkdg--~B/aD0yNzI7dz0xMDg2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/793a6088cf57350909b609fadb03a27d","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/oSggiPuAItNxnau.XMmkdg--~B/aD0yNzI7dz0xMDg2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/793a6088cf57350909b609fadb03a27d"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cardio-diagnostics-announces-epi-gen-123100092.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4504","MDWT","BK4139","BK4585","CDIO","BK4588","CDIOW","BK4162","BK4196","CHD","FMS","BK4018","GEN"],"gpt_icon":0},{"id":"2446668843","title":"Cardio Diagnostics Announces It’s Exhibiting at the 2024 Onsite Employee Health Clinics Forum","url":"https://stock-news.laohu8.com/highlight/detail?id=2446668843","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2446668843?lang=en_us&edition=fundamental","pubTime":"2024-06-25 20:31","pubTimestamp":1719318660,"startTime":"0","endTime":"0","summary":"CHICAGO, June 25, 2024----Cardio Diagnostics Holdings, Inc. , an AI-driven precision cardiovascular medicine company, announced today that the Company will sponsor a booth and showcase its groundbreaking cardiovascular solutions at the 2024 Onsite Employee Health Clinics Forum, taking place in Chicago, IL, from June 27-28, 2024. The Forum attracts senior executives from various healthcare sectors, including hospitals, health systems, health plans, and employer plans. The event is focused on enabling employers to build, launch, and optimize onsite clinical care facilities that are innovative and effective for their employees.The prevalence of onsite clinics is growing, with 53% of large employers offering them in 2023. Employers are finding that convenience for employees and potential cost savings make onsite clinics an attractive benefits option. The ROI is clear for employers. According to Mercer, employers save an average of $1,800 per employee per year after implementing onsite clin","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/C5DyE7KIB1ToAyTqBEWPsA--~B/aD0yNzI7dz0xMDg2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/a2eb95e26135f84c3bcec3aeccd17fb2","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/C5DyE7KIB1ToAyTqBEWPsA--~B/aD0yNzI7dz0xMDg2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/a2eb95e26135f84c3bcec3aeccd17fb2"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cardio-diagnostics-announces-exhibiting-2024-123100510.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["FET","BK4179","CDIOW","CDIO","BK4139"],"gpt_icon":0},{"id":"2442384935","title":"Cardio Diagnostics Holdings, Inc. Achieves Soc 2 Type I Compliance Certification for Security and Confidentiality","url":"https://stock-news.laohu8.com/highlight/detail?id=2442384935","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2442384935?lang=en_us&edition=fundamental","pubTime":"2024-06-10 20:34","pubTimestamp":1718022850,"startTime":"0","endTime":"0","summary":"Cardio Diagnostics Holdings, Inc. Achieves Soc 2 Type I Compliance Certification for Security and Confidentiality ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20240610:nFWN3I60DQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ON","LU1720051017.SGD","LU2357305700.SGD","BK4141","LU1861220033.SGD","LU0348723411.USD","BK4588","LU1978683503.SGD","BK4139","LU1854104046.USD","LU1854103824.USD","BK4585","LU1861215975.USD","LU1720051108.HKD","LU1548497426.USD","LU0124384867.USD","BK4512","CDIO"],"gpt_icon":0},{"id":"2442496898","title":"Cardio Diagnostics Holdings, Inc. Achieves SOC 2 Type I Compliance Certification for Security and Confidentiality","url":"https://stock-news.laohu8.com/highlight/detail?id=2442496898","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2442496898?lang=en_us&edition=fundamental","pubTime":"2024-06-10 20:31","pubTimestamp":1718022660,"startTime":"0","endTime":"0","summary":"CHICAGO, June 10, 2024----Cardio Diagnostics Holdings, Inc. , a leader in AI-driven precision cardiovascular medicine, today announced the successful completion of its System and Organization Controls  2 Type I audit, achieving compliance with the leading industry standards for customer data security. This milestone underscores the Company’s unwavering commitment to the highest data security standards.\"Achieving SOC 2 Type I compliance reflects our dedication to maintaining the trust of our clients and adhering to industry best practices,\" stated Tim Dogan, Ph.D., Chief Technology Officer of Cardio Diagnostics. \"We take our responsibility seriously, and this accomplishment demonstrates our prioritization of the security and confidentiality of customer data.\". Regular audits and updates to security protocols ensure that the organization remains vigilant against emerging threats. This compliance not only helps adhere to mandatory standards such as HIPAA but also significantly reduces th","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/WOloOOyAeYHKXI8YQhvV.A--~B/aD0yNzI7dz0xMDg2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/25719fdf76c619708bd18f3fdfa8fdb0","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/WOloOOyAeYHKXI8YQhvV.A--~B/aD0yNzI7dz0xMDg2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/25719fdf76c619708bd18f3fdfa8fdb0"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cardio-diagnostics-holdings-inc-achieves-123100347.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ON","LU1854103824.USD","CDIOW","SOC","LU0124384867.USD","BK4588","BK4213","LU2357305700.SGD","BK4139","BK4141","CDIO","LU0348723411.USD","LU1854104046.USD","LU1548497426.USD","LU1720051108.HKD","LU1720051017.SGD","BK4585","BK4512","LU1861215975.USD","LU1978683503.SGD","LU1861220033.SGD"],"gpt_icon":0},{"id":"2441596015","title":"Cardio Diagnostics Holdings Inc -on June 3, Got Notice From Nasdaq, Company Is No Longer in Compliance With Nasdaq Listing Rule 5550(a)(2)","url":"https://stock-news.laohu8.com/highlight/detail?id=2441596015","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2441596015?lang=en_us&edition=fundamental","pubTime":"2024-06-08 04:31","pubTimestamp":1717792318,"startTime":"0","endTime":"0","summary":"Cardio Diagnostics Holdings Inc -on June 3, Got Notice From Nasdaq, Company Is No Longer in Compliance With Nasdaq Listing Rule 5550(a)(2)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20240607:nFWN3I50OQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":[".IXIC","QID","NQmain","LU2210150020.SGD","PSQ","QLD","NDAQ","QQQ","TQQQ","BK4588","BK4139","MNQmain","BK4112","BK4585","LU2210149790.SGD","LU2095319765.USD","SQQQ","CDIO"],"gpt_icon":0},{"id":"2441745398","title":"Benchmark Raises Price Target on Cardio Diagnostics to $2 From $1.35, Maintains Speculative Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2441745398","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2441745398?lang=en_us&edition=fundamental","pubTime":"2024-06-06 22:39","pubTimestamp":1717684767,"startTime":"0","endTime":"0","summary":"(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www.mtnewswires.com/contact-us)Price: 0.68, Change: +0.01, Percent Change: +1.34","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CDIO"],"gpt_icon":0},{"id":"2441745392","title":"Benchmark Raises Price Target on Cardio Diagnostics to $2 From $1.35, Maintains Speculative Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2441745392","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2441745392?lang=en_us&edition=fundamental","pubTime":"2024-06-06 22:39","pubTimestamp":1717684767,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_live","symbols":["BK4006","BK4139","MT","CDIO","BK4561"],"gpt_icon":0},{"id":"2441743480","title":"Cardio Diagnostics Is Maintained at Speculative Buy by Benchmark","url":"https://stock-news.laohu8.com/highlight/detail?id=2441743480","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2441743480?lang=en_us&edition=fundamental","pubTime":"2024-06-06 22:32","pubTimestamp":1717684320,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CDIO/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  June 06, 2024 10:32 ET (14:32 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CDIO"],"gpt_icon":0}],"profile":{"websiteUrl":"http://cardiodiagnosticsinc.com","stockEarnings":[{"period":"1week","weight":0.0408},{"period":"1month","weight":0.2344},{"period":"3month","weight":-0.3712},{"period":"6month","weight":-0.613},{"period":"1year","weight":-0.8788},{"period":"ytd","weight":-0.8934}],"compareEarnings":[{"period":"1week","weight":0.0167},{"period":"1month","weight":0.0303},{"period":"3month","weight":0.0594},{"period":"6month","weight":0.1248},{"period":"1year","weight":0.3088},{"period":"ytd","weight":0.2529}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment test targeting CHD events, including heart attacks; and PrecisionCHD, an integrated epigenetic-genetic blood test for the early detection of coronary heart disease. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is headquartered in Chicago, Illinois.","exchange":"NASDAQ","name":"CARDIO DIAGNOSTICS HOLDINGS INC","nameEN":"CARDIO DIAGNOSTICS HOLDINGS INC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"CARDIO DIAGNOSTICS HOLDINGS INC(CDIO),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest CARDIO DIAGNOSTICS HOLDINGS INC(CDIO) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"CARDIO DIAGNOSTICS HOLDINGS INC,CDIO,CARDIO DIAGNOSTICS HOLDINGS INC股票,CARDIO DIAGNOSTICS HOLDINGS INC股票老虎,CARDIO DIAGNOSTICS HOLDINGS INC股票老虎国际,CARDIO DIAGNOSTICS HOLDINGS INC行情,CARDIO DIAGNOSTICS HOLDINGS INC股票行情,CARDIO DIAGNOSTICS HOLDINGS INC股价,CARDIO DIAGNOSTICS HOLDINGS INC股市,CARDIO DIAGNOSTICS HOLDINGS INC股票价格,CARDIO DIAGNOSTICS HOLDINGS INC股票交易,CARDIO DIAGNOSTICS HOLDINGS INC股票购买,CARDIO DIAGNOSTICS HOLDINGS INC股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"CARDIO DIAGNOSTICS HOLDINGS INC(CDIO),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest CARDIO DIAGNOSTICS HOLDINGS INC(CDIO) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction